WO1994001006A2 - Composition for use as a food or food supplement - Google Patents
Composition for use as a food or food supplement Download PDFInfo
- Publication number
- WO1994001006A2 WO1994001006A2 PCT/GB1993/001409 GB9301409W WO9401006A2 WO 1994001006 A2 WO1994001006 A2 WO 1994001006A2 GB 9301409 W GB9301409 W GB 9301409W WO 9401006 A2 WO9401006 A2 WO 9401006A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- meg
- composition according
- acid
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 103
- 235000013305 food Nutrition 0.000 title claims abstract description 18
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 14
- 229940088594 vitamin Drugs 0.000 claims abstract description 23
- 229930003231 vitamin Natural products 0.000 claims abstract description 23
- 235000013343 vitamin Nutrition 0.000 claims abstract description 23
- 239000011782 vitamin Substances 0.000 claims abstract description 23
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 15
- 235000010755 mineral Nutrition 0.000 claims abstract description 15
- 239000011707 mineral Substances 0.000 claims abstract description 14
- 239000000126 substance Substances 0.000 claims abstract description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 10
- 235000015097 nutrients Nutrition 0.000 claims abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 8
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 8
- 235000020774 essential nutrients Nutrition 0.000 claims abstract description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 6
- 239000011573 trace mineral Substances 0.000 claims abstract description 5
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 5
- 229920001184 polypeptide Polymers 0.000 claims abstract description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 3
- 229940024606 amino acid Drugs 0.000 claims description 43
- 235000001014 amino acid Nutrition 0.000 claims description 43
- 150000001413 amino acids Chemical class 0.000 claims description 43
- 239000000284 extract Substances 0.000 claims description 32
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 26
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 24
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 22
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 22
- 229920002477 rna polymer Polymers 0.000 claims description 20
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 claims description 17
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 claims description 17
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 16
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 14
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 13
- 239000011669 selenium Substances 0.000 claims description 13
- 229910052711 selenium Inorganic materials 0.000 claims description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 12
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 12
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 12
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 12
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 12
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 12
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 12
- 229930003268 Vitamin C Natural products 0.000 claims description 12
- 229930003427 Vitamin E Natural products 0.000 claims description 12
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 12
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 12
- 229960000310 isoleucine Drugs 0.000 claims description 12
- 229930182817 methionine Natural products 0.000 claims description 12
- 239000004474 valine Substances 0.000 claims description 12
- 235000019154 vitamin C Nutrition 0.000 claims description 12
- 239000011718 vitamin C Substances 0.000 claims description 12
- 235000019165 vitamin E Nutrition 0.000 claims description 12
- 229940046009 vitamin E Drugs 0.000 claims description 12
- 239000011709 vitamin E Substances 0.000 claims description 12
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 11
- 239000004475 Arginine Substances 0.000 claims description 11
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 11
- 239000004471 Glycine Substances 0.000 claims description 11
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 11
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 11
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 11
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 11
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 11
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 11
- 239000004472 Lysine Substances 0.000 claims description 11
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 11
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 11
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 11
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 11
- 239000004473 Threonine Substances 0.000 claims description 11
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 11
- 235000004279 alanine Nutrition 0.000 claims description 11
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 11
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 11
- 235000009697 arginine Nutrition 0.000 claims description 11
- 235000003704 aspartic acid Nutrition 0.000 claims description 11
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 11
- 239000011575 calcium Substances 0.000 claims description 11
- 229960000304 folic acid Drugs 0.000 claims description 11
- 235000019152 folic acid Nutrition 0.000 claims description 11
- 239000011724 folic acid Substances 0.000 claims description 11
- 235000013922 glutamic acid Nutrition 0.000 claims description 11
- 239000004220 glutamic acid Substances 0.000 claims description 11
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 11
- 235000013930 proline Nutrition 0.000 claims description 11
- 235000004400 serine Nutrition 0.000 claims description 11
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 11
- 235000002374 tyrosine Nutrition 0.000 claims description 11
- 235000019155 vitamin A Nutrition 0.000 claims description 11
- 239000011719 vitamin A Substances 0.000 claims description 11
- 229940045997 vitamin a Drugs 0.000 claims description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 10
- 229910052791 calcium Inorganic materials 0.000 claims description 10
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 10
- 235000018417 cysteine Nutrition 0.000 claims description 10
- 239000003797 essential amino acid Substances 0.000 claims description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 9
- 210000004204 blood vessel Anatomy 0.000 claims description 9
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 9
- 235000020776 essential amino acid Nutrition 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 210000001519 tissue Anatomy 0.000 claims description 9
- 239000011701 zinc Substances 0.000 claims description 9
- 229910052725 zinc Inorganic materials 0.000 claims description 9
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 8
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 8
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 8
- 229910052804 chromium Inorganic materials 0.000 claims description 8
- 239000011651 chromium Substances 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 8
- 239000011777 magnesium Substances 0.000 claims description 8
- 229910052749 magnesium Inorganic materials 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- 239000011715 vitamin B12 Substances 0.000 claims description 8
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 7
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 7
- 229960002685 biotin Drugs 0.000 claims description 7
- 235000020958 biotin Nutrition 0.000 claims description 7
- 239000011616 biotin Substances 0.000 claims description 7
- 229910052796 boron Inorganic materials 0.000 claims description 7
- 210000003205 muscle Anatomy 0.000 claims description 7
- 229960003512 nicotinic acid Drugs 0.000 claims description 7
- 235000018102 proteins Nutrition 0.000 claims description 7
- 210000003491 skin Anatomy 0.000 claims description 7
- 235000019156 vitamin B Nutrition 0.000 claims description 7
- 239000011720 vitamin B Substances 0.000 claims description 7
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 6
- 239000011716 vitamin B2 Substances 0.000 claims description 6
- 239000011647 vitamin D3 Substances 0.000 claims description 6
- 244000194101 Ginkgo biloba Species 0.000 claims description 5
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 5
- 229960000367 inositol Drugs 0.000 claims description 5
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 5
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 4
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 4
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 4
- 240000000143 Turnera diffusa Species 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 4
- 210000004907 gland Anatomy 0.000 claims description 4
- 235000008216 herbs Nutrition 0.000 claims description 4
- 239000011630 iodine Substances 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 239000007937 lozenge Substances 0.000 claims description 4
- 229910052748 manganese Inorganic materials 0.000 claims description 4
- 239000011572 manganese Substances 0.000 claims description 4
- 229910052750 molybdenum Inorganic materials 0.000 claims description 4
- 239000011733 molybdenum Substances 0.000 claims description 4
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 235000004952 turnera diffusa Nutrition 0.000 claims description 4
- 235000019166 vitamin D Nutrition 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 4
- 229940046008 vitamin d Drugs 0.000 claims description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- 241001061264 Astragalus Species 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 240000003444 Paullinia cupana Species 0.000 claims description 3
- 235000000556 Paullinia cupana Nutrition 0.000 claims description 3
- 235000006533 astragalus Nutrition 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 210000000056 organ Anatomy 0.000 claims description 3
- 210000004233 talus Anatomy 0.000 claims description 3
- 239000011726 vitamin B6 Substances 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- 229930003270 Vitamin B Natural products 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 229960001231 choline Drugs 0.000 claims description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 229940089020 evening primrose oil Drugs 0.000 claims description 2
- 239000010475 evening primrose oil Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 229940107131 ginseng root Drugs 0.000 claims description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
- -1 Valerian Chemical compound 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 239000004554 water soluble tablet Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 description 32
- 239000013522 chelant Substances 0.000 description 24
- 238000009472 formulation Methods 0.000 description 17
- 210000000987 immune system Anatomy 0.000 description 15
- 238000005538 encapsulation Methods 0.000 description 12
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000036541 health Effects 0.000 description 11
- 229960002885 histidine Drugs 0.000 description 10
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 9
- 210000000653 nervous system Anatomy 0.000 description 8
- 230000035882 stress Effects 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 6
- 229960002079 calcium pantothenate Drugs 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 210000002307 prostate Anatomy 0.000 description 6
- 229930003779 Vitamin B12 Natural products 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 210000001685 thyroid gland Anatomy 0.000 description 5
- 235000019163 vitamin B12 Nutrition 0.000 description 5
- 239000011708 vitamin B3 Substances 0.000 description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 229930003471 Vitamin B2 Natural products 0.000 description 4
- 229930003537 Vitamin B3 Natural products 0.000 description 4
- 229930003571 Vitamin B5 Natural products 0.000 description 4
- 206010003246 arthritis Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000009245 menopause Effects 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 229960002477 riboflavin Drugs 0.000 description 4
- 230000001568 sexual effect Effects 0.000 description 4
- 235000019164 vitamin B2 Nutrition 0.000 description 4
- 235000019160 vitamin B3 Nutrition 0.000 description 4
- 235000009492 vitamin B5 Nutrition 0.000 description 4
- 239000011675 vitamin B5 Substances 0.000 description 4
- 235000005282 vitamin D3 Nutrition 0.000 description 4
- 229940033282 vitamin b6 2 mg Drugs 0.000 description 4
- 229940021056 vitamin d3 Drugs 0.000 description 4
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 235000009499 Vanilla fragrans Nutrition 0.000 description 3
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 3
- 210000004100 adrenal gland Anatomy 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000195480 Fucus Species 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 240000003394 Malpighia glabra Species 0.000 description 2
- 235000014837 Malpighia glabra Nutrition 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- 206010029216 Nervousness Diseases 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 240000009164 Petroselinum crispum Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 201000001880 Sexual dysfunction Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 244000126014 Valeriana officinalis Species 0.000 description 2
- 235000013832 Valeriana officinalis Nutrition 0.000 description 2
- 244000263375 Vanilla tahitensis Species 0.000 description 2
- 239000003048 aphrodisiac agent Substances 0.000 description 2
- 230000002509 aphrodisiac effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000133 brain stem Anatomy 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 229940068063 damiana extract Drugs 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 235000011197 perejil Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 210000000515 tooth Anatomy 0.000 description 2
- 235000016788 valerian Nutrition 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UPLPHRJJTCUQAY-WIRWPRASSA-N 2,3-thioepoxy madol Chemical compound C([C@@H]1CC2)[C@@H]3S[C@@H]3C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C)(O)[C@@]2(C)CC1 UPLPHRJJTCUQAY-WIRWPRASSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 1
- 244000098897 Chenopodium botrys Species 0.000 description 1
- 235000005490 Chenopodium botrys Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010305 Confusional state Diseases 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195950 Equisetum arvense Species 0.000 description 1
- 239000005768 Equisetum arvense L. Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000006670 Multiple fractures Diseases 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000007642 Vitamin B Deficiency Diseases 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 229940086392 calcium pantothenate 7 mg Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 235000019993 champagne Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000002451 diencephalon Anatomy 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000005225 erectile tissue Anatomy 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000000796 hypoacidity effect Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940087400 lecithin 50 mg Drugs 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 231100000863 loss of memory Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229940051960 magnesium oxide 50 mg Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 208000001685 postmenopausal osteoporosis Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940051923 vitamin E 15 mg Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a composition for use as a food or food supplement, in particular a food supplement to enhance the lifestyle of men and women.
- the present invention approaches these objects through the use of proteinaceous component and a nutrient compound in a specific ratio.
- a food or food supplement especially one with particular qualities for men and women, can be formulated by combining a proteinaceous component and an essential nutrient component in particular amounts per se and in particular proportions.
- the present invention provides a formulated composition for use as a food or food supplement, which composition comprises a proteinaceous component comprising at least one protein, peptide, polypeptide, or amino acid and an essential nutrient component comprising at least one nutrient substance which is a vitamin, mineral or trace element, the proteinaceous component being present in an amount of from about lxlO "8 g to about 10 g per recommended allowance of at least one nutrient substance in the essential nutrient component.
- the composition of the invention is in discrete portion form.
- such may be in the form of a tablet, pill, lozenge or capsule.
- the composition is in the form of a chewable, suckable, water- soluble or slow-release tablet or lozenge.
- composition of the invention may be in the form of a gum, a powder or a solution or suspension in a non-toxic liquid.
- the composition may include one or more liquid or solid carriers, diluents or excipients.
- the composition may be contained within the shell of a capsule.
- composition of the invention may be formulated in solid form using a carrier etc. comprising maltodextrin.
- the proteinaceous material preferably comprises at least one tissular extract of glands, organs, blood vessels, muscle, skin etc. More preferably, the proteinaceous material comprises at least one tissular extract obtained by purification e.g. by filtration etc., of non-human animal tissue, both foetal and adult, of all types, but excluding bovine tissue.
- the tissular extract for use in the composition of the invention may be prepared in any convenient manner which provides an extract suitable for human consumption.
- the extract is prepared by mixing homogenised tissue material from sheep with homogenised tissue material from pigs. The mixture is then filtered and purified to a degree making it fit for human consumption, after which it may be incorporated in a composition as defined herein.
- tissue material of one species may be introduced into another species to result in the preparation of a specific protein within the host e.g. animal or yeast.
- the proteinaceous material used in the composition of the invention may be ribonucleic acid (RNA) and/or adenosine triphosphate (ATP) .
- RNA ribonucleic acid
- ATP adenosine triphosphate
- the RNA is a naturally occurring RNA such as RNA in yeast or plant proteins and preferably the ATP is that obtained as a cell extract.
- the RNA may be used in an amount of from about 10 to about 50 mg, preferably about 25 mg, per RDA.
- the ATP may be used in an amount of from about 1 to about 10 mg, preferably about 2 mg, per RDA.
- compositions in accordance with the invention may be formulated with the following lifestyle aspects in mind, namely:
- compositions of this invention have put together a mixture of vitamins which are regarded as having some effect on say one's love life. At least they have been publicised as such and during my exhaustive consultations with many of my patients over nearly 30 years, I have found that those who were taking certain of the vitamins and other ingredients contained in the compositions of the invention all claimed that they felt better. Many said that it did seem to have a beneficial effect on lifestyle and well-being with concomitant beneficial effects on, for example, their love life. After all, to have a full and happy love life you have to feel good and energetic and that is what the compositions of this invention are designed to do by supplementing the body's nutrition.
- Specially prepared nutritional proteins of the individual tissues for example, those known to be related to sexual problems. These include the glands, circulatory system and nervous system and are known to add to the potency of this health food supplement.
- Vitamins it is recommended that we all take additional vitamins. It seems that in spite of improvements in farming the food we eat does not generally contain as much of the vitamins that we need. This is very interesting since vitamins are a very important part of nutrition, described in the dictionary as "any of a group of substances that are essential, in small quantities, for the normal functioning of metabolism in the body". They cannot usually be synthesised in the body but they occur naturally in certain foods.
- Vitamin A is vital to the health of the eyes, skin, bone, teeth and immune system.
- vitamin A is regarded as a valuable agent in preventing some of the degenerative diseases associated with ageing. It is regarded as assisting with the protection of the epithelial tissue (cellular tissue covering the whole of the body) against malignant changes (i.e. cancer) . It also prevents the decline in the function of the immune system.
- Vitamin B complex is a large group of some eleven different vitamins. These vitamins are water soluble which means they have to be replenished daily since the body does not store them. Stress for example speeds up our rate of use of the vital B vitamins, so the more stress we are subjected to in our daily lives the more it is necessary to replenish the supplies.
- the B vitamins help with the production of energy within the body.
- the symptoms of vitamin B deficiency include mental fatigue and confusion as well as loss of memory.
- the B vitamins are made up of:
- Thiamine vitamin B important in energy production as well as the condition of the skin and finger nails.
- Folic Acid important for the healthy function of the nervous system, hair, immune system, mucous membranes and liver.
- Pantothenic Acid helps to fight against the effects of stress. It strengthens the adrenal glands and immune system. It is also been used to help people with arthritic diseases.
- Bioti ' n important for the health of the digestive tract, the skin, hair, adrenal glands, thyroid gland, as well as the reproductive system.
- Choline improves the brain and nervous system especially in older people.
- Inositol - helps with the brain and nervous system.
- Vitamin C this vitamin is a major antioxidant. It prevents the formation of free radicals (biological substances which cause havoc to the body) . It is vital to the health of the skin, bones, teeth, blood vessels, tendons and cartilage. The immune system depends upon supplies of vitamin C as does the vital connective tissues. Without this vitamin the body is more likely to suffer infections, poor skin, fatigue, bleeding problems, heart disease, and possibly some forms of cancer.
- Vitamin D often called the sunshine vitamin because the skin manufactures this vitamin when exposed to the sun. It helps with the calcium metabolism and so effects the health of the bones.
- Vitamin E - along with vitamin C this is regarded as the vitamin of youth. Respected as having an influence on sexual function and fertility. It also acts as a strong antioxidant fighting free radicals in the system.
- Preferred levels of vitamins per daily amount of composition may be as follows:
- Vitamin A about 0.5 to about 1.0 mg Vitamin B 1 - about 0.5 to about 1.5 mg Vitamin B 2 - about 0.5 to about 1.7 mg Niacin - about 15.0 to about 19.0 mg Vitamin B 6 - about 1.0 to about 2.2.
- mg Pantothenic Acid - about 5.0 to about 7.0 mg Biotin - about 150.0 to about 200.0 meg Folic Acid - about 300.0 to about 400.0 meg Vitamin B 12 - about 2.0 to about 3.0 meg Vitamin C - about 30.0 to about 60.0 mg Vitamin D 3 - about 2.5 to about 10.0 meg Vitamin E - about 5.0 to about 20.0 mg
- Calcium as well as being vital for the health and development of the bones of the body, calcium also affects the nerves and muscles. Very necessary for women during the menopause to avoid bone problems. Older people generally are prone to developing brittle bones which in turn are prone to easy breakage or fracture.
- Chromium a vital mineral for the utilisation of blood sugars to produce energy. This mineral works closely with the body's natural insulin. Iodine this mineral works on the thyroid gland helping to keep it in balance so improving the overall health of the body and correct metabolism of fats as well as temperature regulation.
- Iron this mineral is important to the structure and function of the haemoglobin, which is a vital part of the red blood cells that carry oxygen around the body. Without iron the blood will not carry oxygen and the result is anaemia and fatigue. Older people are more prone to this condition and it is thought by many to have a direct influence on impotence and sexual problems.
- Magnesium - most cell functions are controlled by this mineral. When this vital mineral is missing or not available in sufficient quantities premature ageing and illness occur.
- Potassium - the muscles of the body depend upon this mineral for their general health and strength.
- Zinc this mineral is important to the health of the prostate, sex glands and organs, the immune system and to the metabolism generally.
- Iodine about 150 meg Fluorine about 1.5 mg, for example, about 1.5 to about 4.0 mg
- Zinc about 15.0 mg Copper from about 2.0 to about 3.0 mg
- Manganese - from about 2.5 to about 5.0 mg, typically about 4 mg
- 200 meg typically about 60 meg Boron - about 1 to about 5 mg, preferably about 2 mg Molybdenum - about 150 meg, for example, about 150 to about 500 meg.
- the amino acids and Aquisetum Arnense which is a natural astringent and also a diuretic which helps the skin to rid itself of toxins and remain youthful, are useful.
- the Fruit Acids can help reduce wrinkles and fine lines.
- boron which is a trace mineral found in plants is beneficial in the prevention of post-menopausal osteoporosis. It is also beneficial in the treatment of arthritis and builds muscle.
- Kelp can help with the thyroid function and Astragalus, which is an ancient Chinese herb can help with the immune system and also with the fight against cancer.
- Bee Pollen is useful.
- the herb myo-inositol can help strengthen the nervous system and lecithin can help the nervous system.
- Ginkgo Biloba which is an ancient Chinese herb may be useful, as well as Kelp and Bee Pollen.
- Ginkgo Biloba which comes from the world's oldest trees may also be useful in rejuvenation or youth products and as a general elixir. It also helps with lung complaints.
- Bee Pollen which helps regenerate the body generally also helps with problems involving the prostate, with arthritis and with heart problems.
- Damiana has aphrodisiac properties and Guarana has stimulatory properties.
- Valerian can help with insomnia and hysteria. It also helps with menstrual problems, general anxiety and nervousness.
- L-Carnitine can help protect the body against cardiovascular disease and against muscular degeneration.
- enzymes which are special proteins each of which accelerates the rate of a specific chemical reaction without taking part in it. Without enzymes life could not exist. They often work together with vitamins and/or minerals.
- Amino acids comprise essential and non-essential amino acids.
- Essential amino acids cannot be made by the body and have to be taken from the food we eat.
- Non-essential amino acids can be made by the body from existing essential amino acids.
- the essential amino acids are:
- isoleucine - which is essential for the formulation of haemoglobin
- threonine - which helps with liver function and in building up the immune system.
- lysine - which inhibits the growth of viruses and aids the adsorption of calcium.
- tryptophan - which has been proposed for the treatment of senile dementia
- methionine - which helps to prevent hair loss and is an anti-fatigue agent
- valine - which is used in the treatment of severe amino acid deficiencies.
- the non-essential amino acids include:
- alanine - which is used by the body to fuel the nervous system and brain. It also builds up the immune system
- arginine - which stimulates the release of growth hormone. It also helps healing and to combat physical and mental fatigue. In addition, it is used in the treatment of liver disorders proline - which is important for the proper function of the joints and tendons, it also helps the heart muscle and is a major constituent of collagen
- cysteine which helps with hair growth. It also helps protect the brain and liver from alcohol and other damage. It helps to detoxify the body
- tyrosine which plays an important part in helping the function of the pituitary gland, as well as adrenal and thyroid gland function. It also helps to generate the production of red and white cells
- glutamic acid - which is important for brain metabolism. It helps the brain to function, it increases blood sugar levels and helps with the management of hypo-glycaemia.
- composition of the invention preferably may include extracts of herbs known to have properties relating say to sexual potency including the herb Damiana found in Mexico, as well as extract of evening primrose oil and ginseng root regarded for a long time as having aphrodisiacal properties.
- composition of the invention may include other ingredients which make it more acceptable for consumption.
- it may include one or more colouring agents for visual effect, one or more flavouring agents such as vanilla for organoleptic effect, as well as flavour enhancers.
- flavouring agents such as vanilla for organoleptic effect
- flavour enhancers such as flavour enhancers.
- ingredients with "health food” overtones may be included such as wheat germ.
- compositions of the invention will now be described in more detail with reference to the following specific Examples.
- composition in accordance with the invention was prepared according to the following formulation:
- Amino Acid Complex 200 mg Ginseng Extract 461 125 mg Silica Dioxide 125 mg Acerola Powder 100 mg Damiana Extract 4.1 75 mg Vitamin C 33 mg 100 Magnesium Stearate 25 mg Vitamin E 15 mg Vanilla 10 mg
- the above formulation was prepared in discrete form as 2 gram (nominal size) suckable tablets with a pleasant vanilla taste and of extremely useful nutritional value.
- composition in accordance with the invention can be prepared according to the following formulation:
- the above formulation was prepared in discrete form as 2 gram chewable/suckable tablets.
- a composition according to Example 2 can be prepared with the addition of the following:
- a composition according to Example 2 can be prepared with the addition of the following:
- a composition according to Example 3 can be prepared with the addition of the following:
- a composition according to Example 5 can be prepared with the addition of the following:
- a composition according to any one of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of ovary, pituitary, thyroid, blood vessels, liver and neurovascular system.
- Example 8
- a composition according to any of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of skin, connective tissue, blood vessels and muscle.
- a composition according to any of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of prostate and blood vessels.
- a composition according to any of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of main brain, hypothalamus, cerebellum and diencephalon.
- a composition according to any of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of liver, colon, stomach and small intestine.
- a composition according to any of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of spleen, thymus, bone marrow, tonsil and sinus.
- a composition according to any of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of cartilage, connective tissue, blood vessels and muscle.
- composition in accordance with the invention, and suitable for encapsulation was prepared according to the following formulation:
- Vitamin C (Ascorbic Acid) 75 mg
- Vitamin D (Cholecalciferol) 10 iu Folic Acid 300 meg
- Vitamin B12 (Cyanocobalamin) 5 meg
- composition believed to be especially useful in the improvement of mental function, and suitable for encapsulation was prepared according to the following formulation:
- composition believed to be useful in the enhancement of heart function and circulation, and suitable for encapsulation was prepared according to the following formulation:
- composition believed to be useful in the control of prostate problems and suitable for encapsulation was prepared according to the following formulation:
- composition believed to be useful in the control of stress and suitable for encapsulation was prepared according to be following formulation:
- composition believed to be useful in maintaining a youthful appearance and temperament, and suitable for encapsulation was prepared according to the following formulation: Ingredient Amount per Capsule
- Vitamin B2 1.6 mg
- composition believed to be useful in the control of rheumatism and arthritis, and suitable for encapsulation was prepared according to the following formulation:
- Vitamin A 750 meg Vitamin Bl 5 mg Vitamin B2 1.6 mg Vitamin B3 18 mg Vitamin B5 5 mg
- composition believed to be useful in the control of immune system problems, and suitable for encapsulation was prepared according to the following formulation:
- composition believed to be useful in the control of menopause problems, and suitable for encapsulation was prepared according to the following formulation:
- composition in accordance with the invention believed to be useful in the control of digestive problems, and suitable for encapsulation was prepared according to the following formulation: Ingredients Amount per Capsule
- Vitamin C (Ascorbic Acid) 30 mg
- Vitamin E (Di-alpha) 20 mg
- composition in accordance with the invention believed to be useful in the control of digestive problems and suitable for encapsulation was prepared according to the following formulation:
- composition in accordance with the invention believed to be useful in the control of weight problems i.e. "slimming", and suitable for encapsulation was prepared according to the following formulation:
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU45099/93A AU4509993A (en) | 1992-07-04 | 1993-07-05 | Composition for use as a food or food supplement |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9214247.0 | 1992-07-04 | ||
GB929214247A GB9214247D0 (en) | 1992-07-04 | 1992-07-04 | Composition for use as a food or food supplement |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994001006A2 true WO1994001006A2 (en) | 1994-01-20 |
WO1994001006A3 WO1994001006A3 (en) | 1994-03-31 |
Family
ID=10718212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1993/001409 WO1994001006A2 (en) | 1992-07-04 | 1993-07-05 | Composition for use as a food or food supplement |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4509993A (en) |
GB (1) | GB9214247D0 (en) |
WO (1) | WO1994001006A2 (en) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2723683A1 (en) * | 1994-08-19 | 1996-02-23 | Boiron | Orally-absorbable nutritional supplement for pregnant females |
FR2723681A1 (en) * | 1994-08-19 | 1996-02-23 | Boiron | Orally-absorbable nutritional supplement for daily admin. to females |
FR2723680A1 (en) * | 1994-08-19 | 1996-02-23 | Boiron | Absorbable nutritional supplement to ensure daily micronutrient intake |
EP0780124A1 (en) * | 1995-12-21 | 1997-06-25 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
AT1808U1 (en) * | 1995-11-16 | 1997-12-29 | Nutrend S R O | MULTI-COMPONENT FOOD SUPPLEMENT |
DE19649730A1 (en) * | 1996-08-08 | 1998-02-12 | Eu Rho Pharma Gmbh | Health product containing minerals and vitamin(s) particularly for smokers |
EP0896817A1 (en) * | 1997-08-13 | 1999-02-17 | Infectopharm Arzneimittel und Consilium GmbH | A zinc containing oral preparation and a procell for preparing it |
WO1999051252A1 (en) * | 1998-04-03 | 1999-10-14 | The Daily Wellness Company | Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation |
WO2000033662A1 (en) * | 1998-12-09 | 2000-06-15 | N.V. Nutricia | Baby food stimulating growth of the thymus |
EP1128835A1 (en) * | 1998-12-28 | 2001-09-05 | Allergy Limited, LLC | Cyanocobalamin (vitamin b 12?) treatment in allergic disease |
WO2002019999A2 (en) * | 2000-09-01 | 2002-03-14 | Sacks Meir S | Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant |
EP1228706A1 (en) * | 2001-01-24 | 2002-08-07 | Sportmedizin Team Vertriebs GmbH | Composition for enhancing the forming of connective tissue and for conditioning the body for high physical performance |
WO2002060278A1 (en) * | 2001-01-29 | 2002-08-08 | Sigma-Tau Healthscience S.P.A. | Food supplement with a slimming effect |
US6497885B2 (en) | 2000-12-22 | 2002-12-24 | The Daily Wellness Company | Method and composition for improving fertility health in female and male animals and humans |
DE10145246A1 (en) * | 2001-09-13 | 2003-04-10 | Pm Internat Ag Luxemburg Luxem | Mixture containing a caffeine-containing substance, especially guarana |
US6974833B2 (en) | 2001-01-16 | 2005-12-13 | Matthias Rath | Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration |
US6989164B2 (en) | 2000-12-22 | 2006-01-24 | The Daily Wellness Company | Method and composition for improving male fertility health |
EP1671630A2 (en) * | 1999-02-05 | 2006-06-21 | Angiogenix, Inc. | L-Arginine based formulations for treating diseases and methods of using the same |
DE102006036887A1 (en) * | 2006-08-04 | 2008-02-07 | Eisele, Guido, Dr. | Composition, useful for caring, promoting growth, strengthening of skin, hair and nails, comprises biotin, cysteine, pantothenic acids and fillers and/or auxiliary materials |
US7371415B1 (en) | 1998-04-03 | 2008-05-13 | The Daily Wellness Company | Method and composition for improving sexual fitness |
US20100151023A1 (en) * | 2006-09-01 | 2010-06-17 | Cathy Beggan | Time delayed release mechanism for energizing composition and method of use |
US10750771B2 (en) | 2011-06-23 | 2020-08-25 | Innovafood Ab | Food supplement comprising amino acid and chromium |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2154397A1 (en) * | 1971-04-08 | 1973-05-11 | Erba Carlo Spa | Nutritive milk additive - to simulate mother's milk contains a high content of nucleic acids |
FR2244468A1 (en) * | 1973-07-31 | 1975-04-18 | Passwater Richard | Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids |
DE2505717A1 (en) * | 1974-02-21 | 1975-08-28 | Sandoz Ag | BEVERAGES |
EP0102663A1 (en) * | 1982-08-10 | 1984-03-14 | Van Melle Nederland B.V. | Supplementary food containing vitamins and/or minerals and optionally further components and a process for producing this food |
EP0259167A2 (en) * | 1986-09-05 | 1988-03-09 | Phillip Lowell Millman | Nutrient composition for athletes and method of making and using the same |
FR2605854A1 (en) * | 1986-10-30 | 1988-05-06 | Futur Quotidien Sa | Dietetic supplement for energy-giving purposes |
EP0302807A2 (en) * | 1987-05-29 | 1989-02-08 | Puleva Union Industrial Y Agro-Ganadera, S.A. | Food products enriched with nucleosides and/or nucleotides and preparation thereof |
-
1992
- 1992-07-04 GB GB929214247A patent/GB9214247D0/en active Pending
-
1993
- 1993-07-05 AU AU45099/93A patent/AU4509993A/en not_active Abandoned
- 1993-07-05 WO PCT/GB1993/001409 patent/WO1994001006A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2154397A1 (en) * | 1971-04-08 | 1973-05-11 | Erba Carlo Spa | Nutritive milk additive - to simulate mother's milk contains a high content of nucleic acids |
FR2244468A1 (en) * | 1973-07-31 | 1975-04-18 | Passwater Richard | Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids |
DE2505717A1 (en) * | 1974-02-21 | 1975-08-28 | Sandoz Ag | BEVERAGES |
EP0102663A1 (en) * | 1982-08-10 | 1984-03-14 | Van Melle Nederland B.V. | Supplementary food containing vitamins and/or minerals and optionally further components and a process for producing this food |
EP0259167A2 (en) * | 1986-09-05 | 1988-03-09 | Phillip Lowell Millman | Nutrient composition for athletes and method of making and using the same |
FR2605854A1 (en) * | 1986-10-30 | 1988-05-06 | Futur Quotidien Sa | Dietetic supplement for energy-giving purposes |
EP0302807A2 (en) * | 1987-05-29 | 1989-02-08 | Puleva Union Industrial Y Agro-Ganadera, S.A. | Food products enriched with nucleosides and/or nucleotides and preparation thereof |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2723681A1 (en) * | 1994-08-19 | 1996-02-23 | Boiron | Orally-absorbable nutritional supplement for daily admin. to females |
FR2723680A1 (en) * | 1994-08-19 | 1996-02-23 | Boiron | Absorbable nutritional supplement to ensure daily micronutrient intake |
FR2723683A1 (en) * | 1994-08-19 | 1996-02-23 | Boiron | Orally-absorbable nutritional supplement for pregnant females |
AT1808U1 (en) * | 1995-11-16 | 1997-12-29 | Nutrend S R O | MULTI-COMPONENT FOOD SUPPLEMENT |
EP0780124A1 (en) * | 1995-12-21 | 1997-06-25 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
DE19649730A1 (en) * | 1996-08-08 | 1998-02-12 | Eu Rho Pharma Gmbh | Health product containing minerals and vitamin(s) particularly for smokers |
EP0896817A1 (en) * | 1997-08-13 | 1999-02-17 | Infectopharm Arzneimittel und Consilium GmbH | A zinc containing oral preparation and a procell for preparing it |
US6368640B1 (en) | 1998-04-03 | 2002-04-09 | The Daily Wellness Company | Method and composition for improving sexual fitness |
WO1999051252A1 (en) * | 1998-04-03 | 1999-10-14 | The Daily Wellness Company | Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation |
US6544563B2 (en) | 1998-04-03 | 2003-04-08 | The Daily Wellness Company | Method and composition for improving sexual fitness |
US7371415B1 (en) | 1998-04-03 | 2008-05-13 | The Daily Wellness Company | Method and composition for improving sexual fitness |
WO2000033662A1 (en) * | 1998-12-09 | 2000-06-15 | N.V. Nutricia | Baby food stimulating growth of the thymus |
US6656903B1 (en) | 1998-12-09 | 2003-12-02 | N. V. Nutricia | Baby food stimulating growth of the thymus |
EP1128835A4 (en) * | 1998-12-28 | 2002-05-02 | Allergy Ltd Llc | Cyanocobalamin (vitamin b 12?) treatment in allergic disease |
EP1128835A1 (en) * | 1998-12-28 | 2001-09-05 | Allergy Limited, LLC | Cyanocobalamin (vitamin b 12?) treatment in allergic disease |
EP1671630A3 (en) * | 1999-02-05 | 2007-05-09 | Angiogenix, Inc. | L-Arginine based formulations for treating diseases and methods of using the same |
EP1671630A2 (en) * | 1999-02-05 | 2006-06-21 | Angiogenix, Inc. | L-Arginine based formulations for treating diseases and methods of using the same |
WO2002019999A3 (en) * | 2000-09-01 | 2003-03-27 | Meir S Sacks | Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant |
US7128930B1 (en) | 2000-09-01 | 2006-10-31 | Meir S. Sacks | Compositions and methods for treating sexual dysfunction |
WO2002019999A2 (en) * | 2000-09-01 | 2002-03-14 | Sacks Meir S | Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant |
US6497885B2 (en) | 2000-12-22 | 2002-12-24 | The Daily Wellness Company | Method and composition for improving fertility health in female and male animals and humans |
US6989164B2 (en) | 2000-12-22 | 2006-01-24 | The Daily Wellness Company | Method and composition for improving male fertility health |
US7045151B2 (en) | 2000-12-22 | 2006-05-16 | The Daily Wellness Company | Method and composition for improving fertility health in female and male animals and humans |
US6974833B2 (en) | 2001-01-16 | 2005-12-13 | Matthias Rath | Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration |
EP1228706A1 (en) * | 2001-01-24 | 2002-08-07 | Sportmedizin Team Vertriebs GmbH | Composition for enhancing the forming of connective tissue and for conditioning the body for high physical performance |
US8207109B2 (en) | 2001-01-29 | 2012-06-26 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Food supplement with a slimming effect |
WO2002060278A1 (en) * | 2001-01-29 | 2002-08-08 | Sigma-Tau Healthscience S.P.A. | Food supplement with a slimming effect |
DE10145246A1 (en) * | 2001-09-13 | 2003-04-10 | Pm Internat Ag Luxemburg Luxem | Mixture containing a caffeine-containing substance, especially guarana |
DE102006036887A1 (en) * | 2006-08-04 | 2008-02-07 | Eisele, Guido, Dr. | Composition, useful for caring, promoting growth, strengthening of skin, hair and nails, comprises biotin, cysteine, pantothenic acids and fillers and/or auxiliary materials |
DE102006036887B4 (en) * | 2006-08-04 | 2016-09-29 | Guido Eisele | Composition for a means of care, growth promotion and strengthening of skin, hair and nails and its use |
US20100151023A1 (en) * | 2006-09-01 | 2010-06-17 | Cathy Beggan | Time delayed release mechanism for energizing composition and method of use |
US8968799B2 (en) * | 2006-09-01 | 2015-03-03 | Rise-N-Shine L.L.C. | Time delayed release mechanism for energizing composition and method of use |
US10750771B2 (en) | 2011-06-23 | 2020-08-25 | Innovafood Ab | Food supplement comprising amino acid and chromium |
US11937624B2 (en) | 2011-06-23 | 2024-03-26 | Innovafood Ab | Food composition |
Also Published As
Publication number | Publication date |
---|---|
AU4509993A (en) | 1994-01-31 |
GB9214247D0 (en) | 1992-08-19 |
WO1994001006A3 (en) | 1994-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994001006A2 (en) | Composition for use as a food or food supplement | |
GB2268871A (en) | Composition for use as a food or food supplement | |
US6193973B1 (en) | Dietary supplement for boosting energy and increasing muscular strength | |
CA2487588C (en) | Drink composition and a method for composing a drink | |
CN108651998A (en) | It is a kind of have relieve fatigue PURE WHEY of function and preparation method thereof | |
MX2007007731A (en) | Formula ions and treatments for well-being. | |
JP2012171901A (en) | Food for oral-intake for hair growth of men | |
KR100463414B1 (en) | Food-supplement for sports nutrition | |
KR100509983B1 (en) | Healthy food composition for accelerating growth | |
CN101991110B (en) | Wild ganoderma lucidum food | |
RU2685883C1 (en) | Vitaminized drinking water | |
CN109845870A (en) | A kind of haematococcus pluvialis vitamin C pressed candy and preparation method thereof | |
CN103478718B (en) | Improve functional food of glutathione concentration in human body and preparation method thereof | |
CN102579956B (en) | Medicament composition and application thereof | |
CN108450962A (en) | A kind of solid beverage and preparation method thereof for Woman health | |
CN107136490A (en) | A kind of peptide Chinese caterpillar fungus health product | |
CN106509900A (en) | Tuber magnatum health-care product | |
JP2001348334A (en) | Nutrition supplement | |
Dorn et al. | A review of antler supplements: Benefits, trends, and potential | |
RU2259147C2 (en) | Dioactive additive | |
RU2323599C1 (en) | Biologically active food additive and its production method | |
KR20030033099A (en) | Nutrition food composition | |
RU2796461C1 (en) | Food product based on natural bee honey | |
WO2013009194A1 (en) | Food supplement having high immunological value, based on a protein matrix | |
RU2496346C1 (en) | Biologically active additive for body defences strengthening |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: CA |